Get all your news in one place.
100's of premium titles.
One app.
Start reading
Daily Record
Daily Record
Lifestyle
Tim Hanlon & Jacob Rawley

Doctors amazed by experimental cancer drug that 'cures' every patient in trial

An experimental cancer drug has shown promising success, apparently curing all the patients involved in its trial.

The drug, called dostarlimab, may provide a cure for a form of rectal cancer with 100% of the 18 participants seemingly overcoming the condition with minimal side effects.

The participants received the drug every three weeks for six months for the study which was carried out by Memorial Sloan Kettering Cancer Center (MSKCC), the Mirror reports.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.